Literature DB >> 22264945

Time trends in the incidence and causes of blindness in Israel.

Alon Skaat1, Angela Chetrit, Michael Belkin, Michael Kinori, Ofra Kalter-Leibovici.   

Abstract

PURPOSE: To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008.
DESIGN: Descriptive, retrospective population-based study.
METHODS: During the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and were reviewed retrospectively. Specific rates by age, gender, calendar year, and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models.
RESULTS: The age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8 per 100 000 in 1999 to 16.6 per 100 000 in 2008. The decline mainly was attributable to a decreased incidence of blindness resulting from age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract.
CONCLUSIONS: Contemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22264945     DOI: 10.1016/j.ajo.2011.08.035

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  31 in total

1.  [Requirements for low vision magnification aids in age-related macular degeneration: Data from the Tübingen low vision clinic (comparison of 2007-2011 with 1999-2005)].

Authors:  E K Altpeter; N X Nguyen
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

2.  The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration.

Authors:  Frank A Sloan; Brian W Hanrahan
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

3.  A novel EyePhone© App for improving adherence to glaucoma therapy.

Authors:  Ari Leshno; Dan Gaton; Reut Singer; Elior Eliasi; Ofri Vorobichik-Berar; Shiran Madgar; Ori Stern; Wasim Jaber; Noa Kapelushnik; Alon Skaat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-02       Impact factor: 3.117

4.  [Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice].

Authors:  B Heimes; T Schick; C K Brinkmann; A Wiedon; B Haegele; B Kirchhof; F G Holz; D Pauleikhoff; F Ziemssen; S Liakopoulos; G Spital; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

5.  Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Authors:  Heiner Claessen; Jutta Genz; Bernd Bertram; Christoph Trautner; Guido Giani; Iris Zöllner; Andrea Icks
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

6.  Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age-related macular degeneration in a well-defined region of the United Kingdom.

Authors:  M Buckle; A Lee; Q Mohamed; E Fletcher; A Sallam; R Healy; I Stratton; A Tufail; R L Johnston
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

7.  Rate of vision loss in neovascular age-related macular degeneration explored.

Authors:  Juan P Real; Gladys E Granero; Mariana O De Santis; Claudio P Juarez; Santiago D Palma; Simon P Kelly; José D Luna
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-11       Impact factor: 3.117

8.  Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.

Authors:  Arseniy P Yashkin; Paul Hahn; Frank A Sloan
Journal:  Ophthalmology       Date:  2016-08-11       Impact factor: 12.079

9.  Blindness and visual impairment in Germany: a slight fall in prevalence.

Authors:  Robert P Finger; Bernd Bertram; Christian Wolfram; Frank G Holz
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

Review 10.  Markedly decreasing incidence of cause-specific blindness in Saxony (Eastern Germany).

Authors:  Heiner Claessen; Tatjana Kvitkina; Maria Narres; Christoph Trautner; Bernd Bertram; Andrea Icks
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.